[Interleukin-2 in the treatment of malignant diseases: results and perspectives].
Hercend
T
T
Laboratoire d'Hémato-Immunologie, Institut Gustave-Roussy, INSERM U 333, Villejuif, France.
D000230:Adenocarcinoma / Q000188:drug therapy; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy; D008545:Melanoma / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*
D007376:Interleukin-2
Résultats globaux et perspectives de l'interleukine-2 dans le traitement des affections malignes.